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RESEARCH PAPER HIGHLIGHTS
KNOWN FACTS- Diabetes Mellitus is a potential epidemic in Asia and India 
being the diabetic capital. Diabetes causes various foot complications with 
underlying peripheral neuropathy. The most important etiological factor for a 
diabetic foot is high/altered plantar pressure.
Novelty and Highlights:
1. The study determined the peak plantar pressure difference between type 2 
diabetes mellitus with and without neuropathy
2. The study focused on the most important clinical parameters that could be 
associated with peak plantar pressure in type 2 diabetes mellitus participants.
3. The clinical variables like severity of neuropathy, varicosity, plantar 
cushioning, dynamic knee joint angle, and angular ankle joint velocity were 
important predictors for peak plantar pressure.
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1 Prediction of Peak Plantar Pressure for Diabetic Foot: The Regressional 
2 Model
3 Abstract:
4 Background: The increase in peak plantar pressure could be the most important 
5 etiological factor for pathogenesis of a Diabetic Foot. Thus the fate of a diabetic 
6 foot syndrome which is a clinical triad of neurological, vascular and 
7 musculoskeletal changes could be biomechanically predictive and preventive using 
8 clinical parameters. In the presence of peripheral neuropathy, certain clinical 
9 parameters could be severely altered resulting into increased peak plantar pressure. 
10 Therefore the aim of the study was to identify the most important clinical 
11 parameters for the prediction of peak plantar pressure between neuropathy and 
12 non-neuropathy type 2 diabetes mellitus participants. Methodology: A total of 380 
13 participants were recruited under the study and divided into two groups (190 each 
14 group). The cross-sectional study was conducted at Kasturba Hosipal, 
15 Manipal,India. Multiple regression analysis was performed to find the hyperplane 
16 of best fit. Stepwise regression was performed with (α entry=.15 and α removal= 
17 .2) to select the best subset of predictors. Results: Adjusted R2 of the final model 
18 which included the predictors showed 90.8% variability for the dependent variable. 
19 Conclusion: The findings from the regression analysis and suggested model was 
20 found be strongly significant in predicting the peak plantar pressure between 
21 neuropathy and non-neuropathy type 2 diabetes mellitus participants. Since higher 
22 values of peak plantar pressure is strongly associated with risk for future diabetic 
23 foot complications, it could be suggested that these clinical parameters could be 
24 very useful to assess and should be used in routine clinical practice very 
25 effectively.
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32 INTRODUCTION: Foot complications are the most ignored part of diabetes 
33 management. The increase in peak plantar pressure could be the most important 
34 etiological factor for pathogenesis of a Diabetic Foot [2]. Diabetic Foot Syndrome 
35 (DFS) as defined by the World Health Organization is an “ulceration of the foot 
36 (distally from the ankle and including the ankle) associated with neuropathy and 
37 different grades of ischemia and infection” [3]. Thus the fate and pathophysiology 
38 of a diabetic foot syndrome include a clinical triad of neurological, vascular and 
39 musculoskeletal changes which could be biomechanically predictive and 
40 preventive using clinical parameters. In the presence of peripheral neuropathy, 
41 certain clinical parameters could be severely altered resulting into increased peak 
42 plantar pressure [1]. For e.g. the sensory deficit leads to common foot 
43 complications like altered sensations (tingling,burning, pricking, hypoesthesia, 
44 allodynia). The sensory deficit could be clinicaly manifested with the loss of 
45 protective sensation initially (touch and temperature), and progression to damage 
46 of large diameter sensory fibers (vibration loss) [4]. The motor neuropathy presents 
47 as weakness and atrophy of intrinsic and extrinsic foot muscles at ankle, and leads 
48 to common foot deformities like claw toes, hammer toes, equinus, Charcot foot, 
49 changes in foot arch, tightness of plantar aponeurosis, etc. The primary changes in 
50 the musculoskeletal structures could also be associated with consequent secondary 
51 changes in joint structure and function like the decreased range of motion [5].  The 
52 vascular changes are often seen as reduced blood supply to peripheral 
53 microvasculature of foot. Vascular insufficiency may be clinically manifested by 
54 the altered ankle brachial index (ABI), blackish discoloration of the foot, altered 
55 temperature of the foot. Autonomic neuropathy and dermatological changes are the 
56 most common manifestation that accounts for 47.5-91.2 % of people with type 2 
57 diabetes mellitus [6]. Decreased blood circulation can lead to changes in the skin 
58 collagen altering its texture, appearance, and ability to heal. As a result, the skin’s 
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59 endothelial cells get damaged, and this may even reduce its ability to sweat which 
60 leads to dry skin, fissure and callus formation as well as a decrease in the ability to 
61 sense temperature and pressure [7].Studies have reported that the increase in peak 
62 plantar pressure and repetitive micro trauma due to higher ground reaction force 
63 (GRF) could be the most important etiological factor for pathogenesis of a DFS 
64 [8].Similar finding were supported by another study which concluded 57% higher 
65 risk for ulceration at high pressure points. The individual areas of foot like hallux, 
66 metatarsal heads, midfoot and heel were positively associated with the peak plantar 
67 pressure and incidence of foot ulcers [9].While studying the presentation and 
68 causative factors, it is now understood that DFS could be biomechanically 
69 determinative predominately by increased plantar pressure/ ground reaction force. 
70 Thus with a detailed clinical evaluation, and identification of clinical parameters 
71 which could be closely associated with high plantar pressure, the risk of future 
72 diabetic foot complications could be predicted and prevented. Therefore the aim of 
73 the study was to identify the most important clinical parameters of diabetic foot 
74 which could be the predictors of the peak plantar pressure in diabetic foot. The 
75 objectives of the study were as follows:
76 1.To find a line of hyper plane between the neurological, vascular, musculoskeletal
77 and biomechanical findings with maximum/peak plantar pressure among 
78 participants with type 2 diabetes mellitus.
79 2. To provide regression equation and prediction model for peak plantar pressure
80 distribution between neuropathy and non-neuropathy type 2 diabetes mellitus 
81 participants.
82 METHODOLOGY:
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83 Study Design and Settings: The observational cross-sectional study was 
84 conducted at Diabetic Foot Clinic, Kasturba Hospital, Manipal, Karnataka India. 
85 The study is a part of PhD. 
86 Study Population: All diagnosed type 2 diabetes mellitus participants were 
87 recruited under the purposive sampling method. A total of 380 participants (the 
88 sample size was taken as a part of PhD study using the formula for comparison of 
89 mean for outcome like peak plantar pressure) were recruited under the study. The 
90 participants were divided into two equal groups (n=190 each)  in order  to 
91 determine the change in plantar pressure distribution and its association with 
92 clinical parameters between participants with type 2 DM with neuropathy and type 
93 2 DM without neuropathy . Neuropathy subjects have been graded and compared 
94 with non-neuropathy group as the reference in the equation
95 Study Procedure: The ethical clearance for was obtained from Institutional Ethics 
96 Committee. An informed consent was obtained from all participants following 
97 which a detailed diabetic foot evaluation was taken including neurological, 
98 vascular, musculoskeletal and biomechanical findings. It is well known that plantar 
99 pressure is severely affected by presence of peripheral neuropathy. Therefore 
100 screening for the presence of diabetes peripheral neuropathy is important. The 
101 presence of neuropathy was confirmed with findings from Monofilament and 
102 Vibration pressure threshold (VPT) values. The VPT values were also used to 
103 further stratify the grades of neuropathy. A value of 1 to 14 volts was reported as 
104 the absence of neuropathy, 14 to 20 volts as a risk for neuropathy, and values 
105 above 20 volts were considered as neuropathy among Indian population based on 
106 previous literature [10].The protective sensation testing was performed using the 
107 standard procedure for 5.07/10g Semmes Weinstein Monofilament Test and 
108 vibration sense testing using biothesiometer (Vibration Pressure threshold 
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109 Device/VPT). Semmes Weinstein 10 g Monofilament Testing is a widely used 
110 neuropathy screening tool in diabetes mellitus. A systematic review was done on 
111 the use of Semmes Weinstein Monofilament as a diabetic neuropathy screening 
112 tool used in various studies. The study concluded that it had a sensitivity ranging 
113 from 57% to 93%, specificity ranging from 75% to 100% and a positive predictive 
114 value ranging from 84% to 100% whereas negative predictive value is ranging 
115 from 36% to 94% [11]. Similar to 10 g Monofilament, VPT testing is a valid, 
116 reliable and cost-effective clinic tool to diagnose neuropathy compared to a gold 
117 standard like Nerve Conduction Velocity. A study was conducted by Kaur and 
118 Singh (2016) to test VPT as a measure of distal symmetrical polyneuropathy 
119 (DSPN) in type 2 diabetes mellitus [12]. The study concluded that VPT was a 
120 reliable measure for DSPN with good sensitivity (74.07%) and specificity to 
121 diagnose clinical neuropathy. Following the confirmation of DPN, other clinical 
122 variables were obtained which consisted of more than 150 direct variables and 348 
123 sub-variables into the assessment.  The variables includes in the study were 
124 selected and categorized based on the standard diabetic foot evaluation and their 
125 association with maximum plantar pressure. In the present study we have listed the 
126 variables that could alter the plantar pressure directly or indirectly as listed here. 
127 The independent variables (continuous and categorical) consisted of group, 
128 gender,age, height, weight, body mass index (BMI), duration of diabetes, 
129 occupation, Fasting blood sugar (FBS), post-prandial blood sugar (PPBS), HbA1c, 
130 ankle brachial index (ABI), type of hypoglycemic agent (oral, insulin 
131 etc),smoking, alcohol, family history, ankle static angle (ASA), ankle heel-strike 
132 angle (AHSA), ankle toe-off angle (ATOA), knee static angle (KSA), knee heel-
133 strike angle (KHSA), knee mid-stance angle (KMSA), knee toe-off angle (KTOA), 
134 ankle heel-strike velocity (AHSV), ankle mid-stance velocity (AMSV),  ankle toe-
135 off velocity (ATOV), knee heel-strike velocity (KHSV), knee mid-stance velocity 
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136 (KMSV), knee toe-off velocity (KTOV), ankle heel-strike acceleration (AHSAA), 
137 ankle midstance acceleration (AMSAA), ankle toe-off acceleration (ATOAA),knee 
138 heel-strike acceleration (KHSAA), knee mid-stance acceleration (KMSAA), knee 
139 toe-off acceleration (KTOAA), sensation (touch), ankle reflex, pedal pulse, 10 g 
140 monofilament testing, grades of neuropathy (VPT), muscle tightness, dryness of 
141 skin, discoloration of feet, toe deformities like hallux valgus, clawing and hammer 
142 toes, ingrown nails, callus, fissures, prominent metatarsal heads, peripheral 
143 vascular disease, obesity, hypertension, levels of physical activity, vascular and 
144 neurological claudication, pedaledema, varicosity, nephropathy ,retinopathy 
145 plantar fasciitis ,flexible footwear, rigid footwear ,specialised footwear 
146 (micrcellulose rubber), plantar fat pad, max.pressure area, step-time, swing time, 
147 double-stance time, gait cycle time, stride time, step-length, gait cycle length, foot 
148 angle, foot archtype (cavus/planus), first ray length, fifth ray length, Naviculardrop 
149 height, foot posture index  (FPI), extensor halluces strength (EHMMT), ankle 
150 dorsiflexor strength (ADMMT), plantar flexor strength (PFMMT), knee flexor 
151 strength (KFMMT), hip abductor strength (HABMMT), gastrocnemius tightness , 
152 soleus tightness, quadriceps tightness, hip adductor tightness, hip abductor 
153 tightness, Illio-tibial band tightness, hamstring tightness, Q angle, Neuropathy 
154 scales including Michigan Neuropathy Screening Instrument, Leeds Asseesment of 
155 Neuropathy Signs and Symptoms, Douleur Neuropathique 4, Neuropathy disability 
156 score, Neuropathy Symptoms score respectively (MNSIA, MNSIB, LANSS, DN4, 
157 NDS, NSS), postural analysis including forward neck, forward shoulder, 
158 cervicallordosis, kyphosis, lumbar lordosis, scoliosis, pelvis tilt, femoral rotation, 
159 genu valgus/varum, patella shift, tibia torsion, and calcaneum neutral. Various sub-
160 analysis were also perform and variables were used. Since it is well known that 
161 higher plantar pressure is the most important outcome for predicting diabetic foot 
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162 syndrome and future ulcerations, we selected peak/maximum pressure as the 
163 dependent variable.
164 The biochemistry profile for all diabetes mellitus participants were taken from the 
165 laboratory findings. The clinical assessment for detection of peripheral neuropathy 
166 was performed as per the standard guidelines using MNSI 10 g Monofilament, and 
167 VPT testing by a clinician. The muscle strength was determined by the Manual 
168 Muscle Testing Grading system by a skilled physiotherapist. For kinematic 
169 analysis 2D/3D SIMI Motion GmbH analysis system was used using two high 
170 speed infrared cameras and 9 mm retro-reflective marker sets for ankle and knee 
171 joints [23].  Motion analysis system is the gold standard tool for determining the 
172 joint kinematics in the current state of art. The kinetic analysis for peak plantar 
173 pressure was obtained using the Wintrack Dyanamic Foot Scanner 
174 (MEDICAPTEURS Technology France). The data was captured for barefoot 
175 analysis.
176 Statistical Analysis: The data was analyzed using SPSS15. Multiple regression 
177 analysis was performed to find the hyperplane of  best fit. Stepwise regression was 
178 performed with (αentry=.15 and αremoval= .2) to select the best subset of predictors. 
179 The predictors in the final model had Variance Inflation Factor less than 5 which 
180 confirms the absence of possible multicollinearity between predictors. Comparison 
181 of neuropathy subjects at various grades with non-neuropathy subjects as reference 
182 have been performed by Wald t test and reported in the table with p values.
183 RESULTS: The multiple linear regression analysis for prediction of maximum 
184 plantar pressure was performed. The descriptive data for blood profile and 
185 anthropometry has been shown in Table 1 below. Table 2 represents the duration 
186 of diabetes mellitus and severity grading among the neuropathy group of 
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187 participants. Table 3 represents the estimation of  maximum plantar pressure using 
188 the regression model.
189 Table 1:  Descriptive for Anthropometric and Blood profile of all Participants
VARIABLES GROUP GENDER MEAN±S.D
NEUROPATHY
(n =190)
OVERALL
MALE (145) 
FEMALE (45)
57.65±10.77
58.98±10.56
50.60±10.17
AGE  in years
NON-NEUROPATHY
(n=190)
OVERALL
MALE (142) 
FEMALE (48)
53.12±10.36
53.65±10.24
50.51±10.61           
NEUROPATHY
(n =190)
OVERALL
MALE (145) 
FEMALE (45)
164.57±8.22
167.36±6.13
152.5±4.44
HEIGHT in cm
NON-NEUROPATHY
(n=190)
OVERALL
MALE (142) 
FEMALE (48)
164.98±8.55
167.4±6.97
154.19±5.94
NEUROPATHY
(n =190)
OVERALL
MALE (145) 
FEMALE (45)
71.26±10.62
72.66±10.4
65.16±9.63WEIGHT in kg
NON-NEUROPATHY
(n=190)
OVERALL
MALE (142) 
FEMALE (48)
70.32±10.22
71.09±10.29
67.23±9.24
NEUROPATHY
(n =190)
OVERALL
MALE (145) 
FEMALE (45)
26.35±3.32
25.94±3.63
28.12±4.27Body Mass Index (BMI)
NON-NEUROPATHY
(n=190)
OVERALL
MALE (142) 
FEMALE (48)
25.90±2.13
25.40±3.66
28.26±3.39
NEUROPATHY
(n =190
OVERALL
MALE (145) 
FEMALE (45)
194.25±66.65
193.96±70.34
198.46±48.89
Fasting Blood Sugar (FBS) in 
mg/dL
NON-NEUROPATHY
(n=190)
OVERALL
MALE (142) 
FEMALE (48)
158.43±48.43
159.4±51.73
152.26±32.17
Post Prandial Blood Sugar 
(PPBS) in mg/dL
NEUROPATHY
(n =190)
OVERALL
MALE (145) 
276.63±74.41
278.47±78.34
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FEMALE (45) 285.43±55.18
190
191 Table2. Duration of diabetes and severity of neuropathy among DPN group.
Parameters Frequency (N %)
1-5 years 56(29.47%)    
6-10 years 63(33.15 %)       
11-15 years 38 (6.7%)          
16-20 years 19 (20%)   
21-25 years 07 (3.68%)
26-30 years 06(1.1%)
>31 years 01 (0.52%)
Duration of 
Diabetes with 
Neuropathy
TOTAL        190(100%)
MILD 43 (22.63%)
MODERTAE 57 (30%)
SEVERE 90 (47.36%)
Grades of 
Neuropathy
(Vibration 
Pressure 
Threshold 
Testing)
TOTAL 190 (100%)
192 Table 3. Maximum Plantar Pressure Prediction: Parameter estimates using regression 
193
95% Confidence Interval 
Predictors Estimates t value P value Lower Bound Upper Bound
Partial Eta 
Squared
GRADES NEUROPATHY
MILD 168.758 16.806 < 0.001 149.035 188.482 .337
MODERATE 184.611 17.817 < 0.001 164.258 204.963 .364
SEVERE 186.004 19.656 < 0.001 167.416 204.591 .410
NORMAL . . . . . .
VARICOSITY
YES 17.751 2.809 0.005 5.340 30.162 .014
NO . . . . . .
PLANTAR CUSHION
POOR 19.724 4.356 < 0.001 10.830 28.617 .033
FAIR -3.239 -0.683 0.495 -12.558 6.079 .001
GOOD . . . . . .
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KMSA (°) -1.106 -2.574 0.010 -1.950 -0.262 .012
NSS 5.354 4.330 0.000 2.925 7.782 .033
FOOTANGLE (°) 1.049 2.427 0.016 0.200 1.898 .010
KTOAA (°/s²) 0.032 2.844 0.005 0.010 0.054 .014
KTOV (°/s) 0.276 0.059 < 0.001 0.161 0.392 .038
AHSV (°/s) 0.735 0.176 < 0.001 0.390 1.081 .031
194
195 *KMSA- knee midstance angle, *NSS- neuropathy symptoms score, *KTOAA- knee toe-off acceleration,
196 *KTOV- knee toe-off velocity, *AHSV- ankle heel strike velocity.
197 Adjusted R2 of the final model which included the predictors in table 1 was 90.8%
198 The linear prediction equation obtained using regression analysis is
199 Predicted Maximum Plantar Pressure= 504.14 + 186 Severe Neuropathy 
200 +184.61 Moderate Neuropathy + 168.76 Mild Neuropathy + 17.75 Varicosity+
201 19.72 Poor plantar cushion-3.24 Fair plantar fat pad - 1.11 KMSA + 5.36 NSS + 
202 1.05 Foot angle+0.03 KTOAA+0.28 KTOV+0.74AHSV
203 Here, the predictors such as, Severe Neuropathy, Moderate Neuropathy, Mild 
204 Neuropathy, Varicosity, Poor plantar cushion and Fair plantar cushion are 
205 indicator variables (they take value 1 for presence and 0 for absence)
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214
215 DISCUSSION:
216 The clinical evaluation and clinical assessment of diabetic foot could help to 
217 reduce the risk of future foot complications. The present study highlights that many 
218 clinical parameters interact with each other alter the plantar pressure significantly, 
219 further damaging the foot and increasing the risk of ulceration among diabetes 
220 mellitus. The strength of our study lies in the number of variables assessed and to 
221 the best of our knowledge none of the published studies have reported so many 
222 variables in a single study with a regression euqation.
223 In the present study, we found a regression model which included kinematics and 
224 spatiotemporal parameters gait parameters in addition to neuropathy, vascular, 
225 musculoskeletal and other clinical findings against the Maximum Plantar pressure. 
226 The results from Table 3 suggested that variables like grades of neuropathy, 
227 presence of varicosity, plantar fat pat thickness , knee mid stance angle (KMSA, 
228 angle at knee joint during the midstance phase of gait cyle), Neuropathy Symptoms 
229 Score (NSS) , Foot angle (degree of toe-out or line of progression ), Knee toe-off 
230 acceleration (KTOA, acceleartion at knee joint during toe-off phase of gait cycle), 
231 Knee toe-off velocity(KTOV,velocity at knee joint during toe-off phase of gait 
232 cycle) and ankle heel strike velocity (AHSV,  velocity at ankle joint during heel 
233 strike phase of gait cycle) are significant predictors of maximum plantar pressure. 
234 The coefficient of determination (R2) for the model is 0.908 which suggests that 
235 90.8 % of variability in maximum pressure is explained by the predictors in the 
236 model. The overall F value for model adequacy was observed to be 
237 F(12,568)=469.45, with a corresponding singnficant p value < 0.05.Table3 also 
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238 provides the parameter estimates based on which the linear prediction equation has 
239 been developed. The equation could be explained as below:
240 The equation suggested that grades of neuropathy had a significant impact on 
241 maximum plantar pressure. The regression analysis showed that effect size (partial 
242 eta square) increased with an increase in the grade of neuropathy. It should also be 
243 noted that severe neuropathy could increase the maximum plantar pressure by 
244 186kPa (Table 3) as compared to subjects without neuropathy. Similarly, the poor 
245 plantar fat pad in the feet could lead to increase of maximum plantar pressure by 
246 19.72kPa whereas a fair fat pad could decrease it by 3.23 units as compared to 
247 good fat pad thickness. In the present analysis, variables like knee as well as ankle 
248 velocity and acceleration contributed significantly to the prediction model. It is 
249 observed that elevated values of  knee toe-off velocity, acceleration, and ankle heel 
250 strike velocity lead to an increase in the maximum plantar pressure whereas 
251 increase in knee midstance angle decreases maximum plantar pressure. In other 
252 words, the greater the knee extension, the lower would be the maximum plantar 
253 pressure. In the present study, we find that participants with diabetes peripheral 
254 neuropathy had higher knee flexion angle at mid-stance. Findings from the present 
255 study supports that various clinical parameters could be responsible for increased 
256 maximum pressure which could increase the chances of future foot ulceration 
257 among neuropathy group. The model has highlighted the significance of varicosity 
258 in the lower limb suggesting that peripheral pooling of blood (collection of blood 
259 in the lower limb and reduced blood flow from extremity to the heart) in the feet 
260 could increase the maximum plantar pressure by 17.75kPa as compared to subjects 
261 without varicosity. The results of the present study are similar to the regression 
262 model proposed in the previous literature. However, it should be carefully 
263 understood that these models could be affected by choice of variables, the 
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264 population characteristics, choice and the number of independent variables. To the 
265 best of our knowledge, this could be the first study to propose the Diabetic Foot 
266 prediction model with more than 150 variables among the Indian population. 
267 Ahroni et al. showed that high plantar pressure in diabetic population could be 
268 predicted with clinical parameters like body mass, insulin use, Caucasian race, 
269 gender (male), callus and diabetes duration [13].  In the present study, body mass 
270 was not retained in our clinical model. Cavanaugh et al. also suggested that body 
271 mass was a poor predictor [14]. However, results on gender and diabetes duration 
272 were in consensus with the previous finding and suggested that female gender 
273 showed decreased max. pressure by 19.18 kPa at initial analysis but not retained in 
274 the final model .The results of the present study is also supported by findings of the 
275 study done by Barn et al. which reported that clinical factor like gender, body 
276 mass, diabetes duration, HbA1c, VPT, foot ray (biomechanical axis of the ankle 
277 joint), foot deformity, ankle range of motion and callus were significant predictors 
278 of peak pressure among 167participants [15]. Similar findings were also reported 
279 by Fawzi et al.  in the Egyptian population [16]. Few studies with regression 
280 analysis on gait kinetics and kinematics have been reported previosly. For instance, 
281 the study done by Wrobel et al. suggested that in the multivariate analysis for gait 
282 parameters age, ankle joint mobility, and callus were retained in the model with 
283 17% variance for peak plantar pressure [17]. In the stepwise method, age showed 
284 8.23 % variance; ankle joint mobility showed 3.4% and callus showed 1.4 % 
285 variance.  On the other hand, a study done by Guldemond et al. suggested callus 
286 and toe deformities as relevant predictors of peak forefoot pressure with 26 % of 
287 the variance [18] .Similarly, the study done by Barn et al. suggested that Charcot 
288 foot showed the highest predictor value for peak pressure (Beta coefficient=0.504) 
289 [15]  . In the forefoot, prominent metatarsal head showed the highest contribution
290 of 31 % followed by claw toes. In the present study, we excluded Charcot foot 
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291 however the findings were consistent with prominent metatarsal heads and clawing 
292 of toes at early stage of analysis. However these factors were not retained in the 
293 final model. The study done by Fawzy  et al. [16] suggested that multivariate 
294 logistical regression analysis for ulceration risk was statistically significant for 
295 duration of diabetes (odds ratio [OR] = 0.8), smoking (OR = 9.7), foot 
296 deformity(OR = 8.7), MNDS (OR = 1.5), 2-h postprandial plasma glucose (2 h-
297 PPG) (OR = 0.9), glycated hemoglobin (HbA1c) (OR = 2.1), forefoot peak plantar 
298 pressure(FFPPP,OR = 1.0),and  forefoot peak plantar pressure gradient (FFPPG 
299 ,OR = 1.0).The study done by Al-Rubeaan et al. reported that the risk factors like 
300 Charcot's joints, peripheral vascular disease, neuropathy, diabetes duration≥ 10 
301 years, insulin use, retinopathy, nephropathy, age≥45 years, cerebral vascular 
302 disease, poor glycemic control, coronary artery disease, smoking, and hypertension 
303 was strongly associated with diabetic foot complications [19]. Also the present 
304 clinical model is in consensus with the previous findings with the addition of few 
305 more variables. For e.g., the thickness of plantar fascia or plantar fat pad could be 
306 an important clinical factor for prediction of peak pressure and future risk of 
307 ulceration among participants with diabetes [20].The mechanical properties of 
308 plantar soft tissue can be used to improve the predictability of  diabetic foot ulcers 
309 in moderate/ high-risk patients [21].
310 From the present study, it is evident that the given regression model for diabetic 
311 foot prediction could be an important tool in day to day clinical evaluation for 
312 predicting the maximum plantar pressure and minimizing future foot 
313 complications. Therefore future studies should be done to test the model. Studies 
314 have reported a threshold values for peak plantar pressure. The study from 
315 Armstrong et al. reported that a pressure of 60 N/cm² is the upper threshold for 
316 development of an ulcer in diabetes mellitus [22]. The study also reported a cut-off 
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317 point of 335 kPa (peak plantar pressure) was considered as a risk, for ulceration at 
318 forefoot [22]. However, findings from recent studies have been contradictory. The 
319 study done by Bus et al. suggested that plantar pressure threshold should not be 
320 considered as the suitable method for detecting the risk of foot ulceration in 
321 participants with diabetes [23]. Nevertheless, the higher plantar pressure in the 
322 presence of sensory and motor neuropathy could be a potential risk for foot 
323 ulceration [24] . Thus, higher plantar pressure could be significantly associated 
324 with deformities and soft tissue changes in the foot. Findings from the present 
325 study could help to strengthen the importance of plantar pressure threshold values 
326 with future experimental studies. 
327 Future Scope: The use of the given model could be useful and easier with 
328 advanced biomechanical labs with motion analysis. However it could also be 
329 extended to communities with 2D video analysis through Smartphone’s and freely 
330 available software’s for video analysis to calculate joint angle, velocity and 
331 acceleration. For instance the angular velocity could be obtained by rate change of 
332 angular displacement (radians). Similarly, angular acceleration could be obtained 
333 by the rate change of angular velocity. The study could be useful to carry out 
334 plantar pressure analysis in a clinical population even in the absence of advanced 
335 3D motion analysis system using clinical parameters. However, future studies need 
336 to work out more on the proposed model which could be more user friendly at 
337 clinical and community levels.
338 CONCLUSION: The suggested model was found be strongly significant in 
339 determining the maximum plantar pressure which could be associated with risk of 
340 future foot complications. The study highlighted the most important clinical 
341 parameters while assessing a diabetic foot with neuropathy. Based on the findings 
342 remedies to control plantar pressure could be suggested and rehabilitation protocol 
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343 could be prepared. We believe that the given model is in its primary stage and 
344 future modifications could be required to make it more efficient and user friendly 
345 for routine clinical practice.
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